HomeASND • NASDAQ
add
Ascendis Pharma A/S
Previous close
$122.64
Day range
$122.64 - $130.28
Year range
$90.27 - $161.00
Market cap
7.87B USD
Avg Volume
436.81K
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (EUR) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 57.83M | 20.40% |
Operating expense | 143.38M | -18.10% |
Net income | -99.20M | 38.85% |
Net profit margin | -171.52 | 49.21% |
Earnings per share | -1.72 | 40.28% |
EBITDA | -92.36M | 28.77% |
Effective tax rate | -1.04% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 625.52M | 37.35% |
Total assets | 1.09B | 25.26% |
Total liabilities | 1.19B | 25.82% |
Total equity | -97.32M | — |
Shares outstanding | 57.54M | — |
Price to book | -72.57 | — |
Return on assets | -26.12% | — |
Return on capital | -46.38% | — |
Cash Flow
Net change in cash
| (EUR) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -99.20M | 38.85% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2006
Website
Employees
879
